Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to main study
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) Buch/Monographie |
| Sprache: | Englisch |
| Veröffentlicht: |
London
BioMed Central
2016
|
| DOI: | 10.1186/s12958-016-0164-y |
| Online-Zugang: | Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12958-016-0164-y Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-209255 
|
| Verfasserangaben: | Thomas Strowitzki, Waldemar Kuczynski, Arnd Müller and Peter Bias |
MARC
| LEADER | 00000cam a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1653753803 | ||
| 003 | DE-627 | ||
| 005 | 20250406140734.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 161108s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a urn:nbn:de:bsz:16-heidok-209255 |2 urn | |
| 024 | 7 | |a 10.1186/s12958-016-0164-y |2 doi | |
| 035 | |a (DE-627)1653753803 | ||
| 035 | |a (DE-576)479535159 | ||
| 035 | |a (DE-599)BSZ479535159 | ||
| 035 | |a (OCoLC)965622283 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Strowitzki, Thomas |d 1959- |e VerfasserIn |0 (DE-588)118055917 |0 (DE-627)079216099 |0 (DE-576)17102141X |4 aut | |
| 245 | 1 | 0 | |a Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology |b a phase 3 open-label follow-up to main study |c Thomas Strowitzki, Waldemar Kuczynski, Arnd Müller and Peter Bias |
| 264 | 1 | |a London |b BioMed Central |c 2016 | |
| 300 | |a 1 Online-Ressource (14 Seiten) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Wissenschaftlicher Aufsatz aus: Reproductive Biology and Endocrinology, 14 (2016), Nr. 31. pp. 1-14. ISSN 1477-7827 | ||
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12958-016-0164-y |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-209255 |q application/pdf |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a BO | ||
| 992 | |a 20161108 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 118055917 |a Strowitzki, Thomas |m 118055917:Strowitzki, Thomas |d 910000 |d 910400 |e 910000PS118055917 |e 910400PS118055917 |k 0/910000/ |k 1/910000/910400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1653753803 |e 3368184245 | ||
| BIB | |a Y | ||
| JSO | |a {"person":[{"role":"aut","given":"Thomas","family":"Strowitzki","display":"Strowitzki, Thomas"}],"note":["Wissenschaftlicher Aufsatz aus: Reproductive Biology and Endocrinology, 14 (2016), Nr. 31. pp. 1-14. ISSN 1477-7827"],"title":[{"title_sort":"Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology","subtitle":"a phase 3 open-label follow-up to main study","title":"Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology"}],"origin":[{"publisherPlace":"London","dateIssuedDisp":"2016","dateIssuedKey":"2016","publisher":"BioMed Central"}],"type":{"bibl":"book","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"1 Online-Ressource (14 Seiten)"}],"name":{"displayForm":["Thomas Strowitzki, Waldemar Kuczynski, Arnd Müller and Peter Bias"]},"recId":"1653753803","id":{"eki":["1653753803"],"uri":["urn:nbn:de:bsz:16-heidok-209255"],"doi":["10.1186/s12958-016-0164-y"]}} | ||
| SRT | |a STROWITZKISAFETYANDE2016 | ||